Skip to content

Drug interactions

Eliglustat + Rifaximin

Severity: Minor

Eliglustat and Rifaximin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat inhibits P-glycoprotein, which may raise systemic exposure to rifaximin. Rifaximin is minimally absorbed, so the effect is usually small, but exposure could rise more in patients with hepatic impairment or a damaged gut barrier.

What this interaction means in plain words

Eliglustat and Rifaximin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eliglustat belongs to Miscellaneous; Rifaximin belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Eliglustat inhibits intestinal P-glycoprotein efflux of rifaximin, increasing its absorption.

What to do

No routine dose change is needed. Monitor patients with severe hepatic impairment for rifaximin adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Rifaximin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Rifaximin?

MediHelp rates the interaction as minor. Eliglustat and Rifaximin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eliglustat inhibits P-glycoprotein, which may raise systemic exposure to rifaximin. Rifaximin is minimally absorbed, so the effect is usually small, but exposure could rise more in patients with hepatic impairment or a damaged gut barrier.

How serious is the interaction between Eliglustat and Rifaximin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor patients with severe hepatic impairment for rifaximin adverse effects.

What other medicines interact with Rifaximin?

MediHelp also lists interactions of Rifaximin with, for example, Cholera vaccine, Microbiota, Amiodarone. The full list is on the Rifaximin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in